Cannabis, essential data and knowledge

 

cdegb.jpg

OFDT, 22 p.
May 2009

Cannabis is the most widely available and most used illicit drug in Europe. However, in terms of consumption, France is among the top list countries, at least among young people. Over the past few years, the public authorities have strengthened their efforts to highlight the dangers of this illicit drug. New communication campaigns have been launched via television and other media.
The aim of the present document is to illustrate the different aspects of the situation of cannabis in France (consumption, market, risks and consequences, public policy, etc.). It is essentially based on the monograph published by the French Monitoring Centre for Drugs and Drug Addiction, Cannabis, données essentielles (July 2007), but also relies on several other publications that were published since then as well as updated data in this field, presented throughout the article as footnotes. It seeks to offer a somewhat updated synthesis of this monograph for the English-speaking public and Internet users.

Under the direction of Jean-Michel Costes

Download the PDF file (222 Ko)

Drugs in Europe

2016 EMCDDA European Drug Report

- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe

Country situation summaries

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.